Article Details

Equities Analysts Issue Forecasts for Avid Bioservices, Inc.'s Q2 2022 Earnings (NASDAQ:CDMO)

Retrieved on: 2021-03-10 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Equities Analysts Issue Forecasts for Avid Bioservices, Inc.'s Q2 2022 Earnings (NASDAQ:CDMO). View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 26,859 shares of the biopharmaceutical company's stock valued at $310,000 after acquiring an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up